Key Takeaways The BladderPath study showed mpMRI reduced TTCT by 45 days for MIBC patients, enhancing treatment efficiency without harming non-MIBC patients. Conducted in 17 UK hospitals, the study ...

Incorporating multiparametric MRI (mpMRI) into the initial staging of new bladder cancers may expedite definitive treatment for muscle-invasive bladder cancer (MIBC), recent study findings ...